pembrolizumab,cisplatin,gemcitabine
merck
['key,note,966', 'pembro']
keynote-966 - the largest ever phase iii trial in biliary tract cancer. significant improvement in os with pembrolizumab + gem/cis (12.7 mo. vs. 10.9 w/placebo + gem/cis; hr 0.83). wonderful practice changing contribution by katie kelley et al. #aacr2023 
Mommy of 3 | Physician-Scientist | Transplant Hepatologist @MayoClinic | #TumorImmunology | Tweets are mine. RTs are not an endorsement.